MONTELUKAST AND CETRIZINE MAY AMELIORATE PROGRESSION OF RHEUMATOID ARTHRITIS

Simple item page
dc.creatorNimbalkar, Vikram V
dc.date.accessioned2026-01-10T18:52:13Z
dc.date.available2026-01-10T18:52:13Z
dc.date.issued2016-07-28
dc.descriptionRheumatoid arthritis is an autoimmune disorder. It is a chronic progressive disease resulting in inflammation of joints and painful deformity and immobility of various joints. Being an autoimmune disease, there's lacuna in proper management of the disease. Current options like steroids and DMARD'S (disease modifying anti-rheumatic drugs) are the cornerstone in therapy of the disease, but have their own limitation. New drugs and better methods for management of rheumatoid arthritis are still evolving. The present review highlights the possible involvement of Montelukast, an antagonist of leukotriene receptors and Cetrizine, an antihistaminic drug in amelioration of the progression of the disease.en-US
dc.formatapplication/pdf
dc.identifierhttps://sumathipublications.com/index.php/ijcbr/article/view/38
dc.identifier.urihttps://repos.sumathipublications.com:8000/handle/123456789/36
dc.languageeng
dc.publisherSumathi Publicationsen-US
dc.relationhttps://sumathipublications.com/index.php/ijcbr/article/view/38/pdf
dc.relation.ispartofInternational Journal of Clinical and Biomedical Researchen-US
dc.relation.ispartofseriesVolume 2, Issue 3en-US
dc.rightsCopyright (c) 2016 Vikram V Nimbalkaren-US
dc.sourceInternational Journal of Clinical and Biomedical Research; Volume 2, Issue 3; July 2016; 34-38en-US
dc.source2395-0471
dc.source2521-0394
dc.titleMONTELUKAST AND CETRIZINE MAY AMELIORATE PROGRESSION OF RHEUMATOID ARTHRITISen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Files

Collections

International Journal of Clinical and Biomedical Research (IJCBR)